The global Interventional Oncology Device market size was valued at US$ million in 2023. With growing demand in downstream market, the Interventional Oncology Device is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Interventional Oncology Device market. Interventional Oncology Device are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Interventional Oncology Device. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Interventional Oncology Device market.
Interventional Oncology Device refers to theOncology, like internal medicine, surgery, obstetrics and gynecology, and pediatrics, is a secondary discipline of clinical medicine. It is divided into oncology, oncology radiotherapy, and oncology surgery. Oncology is mainly engaged in medical treatment of various benign and malignant tumors; The Department of Radiation Oncology is mainly engaged in radiotherapy of tumors; oncology surgery provides surgery-based comprehensive treatment. Relevant departments of specialized cancer hospitals will be subdivided according to different parts, such as gastrointestinal oncology and lymphoma oncology in the oncology department; tumor surgery includes breast surgery, head and neck surgery, thoracic surgery, tumor gynecology, and abdominal surgery.
Key Features:
The report on Interventional Oncology Device market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Interventional Oncology Device market. It may include historical data, market segmentation by Type (e.g., Ablation Devices, Embolization Devices), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Interventional Oncology Device market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Interventional Oncology Device market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Interventional Oncology Device industry. This include advancements in Interventional Oncology Device technology, Interventional Oncology Device new entrants, Interventional Oncology Device new investment, and other innovations that are shaping the future of Interventional Oncology Device.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Interventional Oncology Device market. It includes factors influencing customer ' purchasing decisions, preferences for Interventional Oncology Device product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Interventional Oncology Device market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Interventional Oncology Device market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Interventional Oncology Device market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Interventional Oncology Device industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Interventional Oncology Device market.
Market Segmentation:
Interventional Oncology Device market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Ablation Devices
Embolization Devices
Supporting Devices
Next Generation Devices
Segmentation by application
Hospitals
Specialty Clinics and Ambulatory Surgical Centers
Others (Homecare and Research Institutes)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AngioDynamics, Inc.
BD
Boston Scientific Corporation
BTG Plc
Eckert & Ziegler BEBIG
HealthTronics, Inc.
IceCure Medical
Medtronic PLC
Medwaves, Inc.
Merit Medical Systems, Inc.
Sanarus Technologies, Inc.
Sirtex Medical Ltd.
Sonacare Medical
Terumo Corporation
Trod Medical
Cook Meidical LLC
Key Questions Addressed in this Report
What is the 10-year outlook for the global Interventional Oncology Device market?
What factors are driving Interventional Oncology Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Interventional Oncology Device market opportunities vary by end market size?
How does Interventional Oncology Device break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Interventional Oncology Device Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Interventional Oncology Device by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Interventional Oncology Device by Country/Region, 2019, 2023 & 2030
2.2 Interventional Oncology Device Segment by Type
2.2.1 Ablation Devices
2.2.2 Embolization Devices
2.2.3 Supporting Devices
2.2.4 Next Generation Devices
2.3 Interventional Oncology Device Sales by Type
2.3.1 Global Interventional Oncology Device Sales Market Share by Type (2019-2024)
2.3.2 Global Interventional Oncology Device Revenue and Market Share by Type (2019-2024)
2.3.3 Global Interventional Oncology Device Sale Price by Type (2019-2024)
2.4 Interventional Oncology Device Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics and Ambulatory Surgical Centers
2.4.3 Others (Homecare and Research Institutes)
2.5 Interventional Oncology Device Sales by Application
2.5.1 Global Interventional Oncology Device Sale Market Share by Application (2019-2024)
2.5.2 Global Interventional Oncology Device Revenue and Market Share by Application (2019-2024)
2.5.3 Global Interventional Oncology Device Sale Price by Application (2019-2024)
3 Global Interventional Oncology Device by Company
3.1 Global Interventional Oncology Device Breakdown Data by Company
3.1.1 Global Interventional Oncology Device Annual Sales by Company (2019-2024)
3.1.2 Global Interventional Oncology Device Sales Market Share by Company (2019-2024)
3.2 Global Interventional Oncology Device Annual Revenue by Company (2019-2024)
3.2.1 Global Interventional Oncology Device Revenue by Company (2019-2024)
3.2.2 Global Interventional Oncology Device Revenue Market Share by Company (2019-2024)
3.3 Global Interventional Oncology Device Sale Price by Company
3.4 Key Manufacturers Interventional Oncology Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Interventional Oncology Device Product Location Distribution
3.4.2 Players Interventional Oncology Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Interventional Oncology Device by Geographic Region
4.1 World Historic Interventional Oncology Device Market Size by Geographic Region (2019-2024)
4.1.1 Global Interventional Oncology Device Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Interventional Oncology Device Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Interventional Oncology Device Market Size by Country/Region (2019-2024)
4.2.1 Global Interventional Oncology Device Annual Sales by Country/Region (2019-2024)
4.2.2 Global Interventional Oncology Device Annual Revenue by Country/Region (2019-2024)
4.3 Americas Interventional Oncology Device Sales Growth
4.4 APAC Interventional Oncology Device Sales Growth
4.5 Europe Interventional Oncology Device Sales Growth
4.6 Middle East & Africa Interventional Oncology Device Sales Growth
5 Americas
5.1 Americas Interventional Oncology Device Sales by Country
5.1.1 Americas Interventional Oncology Device Sales by Country (2019-2024)
5.1.2 Americas Interventional Oncology Device Revenue by Country (2019-2024)
5.2 Americas Interventional Oncology Device Sales by Type
5.3 Americas Interventional Oncology Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Interventional Oncology Device Sales by Region
6.1.1 APAC Interventional Oncology Device Sales by Region (2019-2024)
6.1.2 APAC Interventional Oncology Device Revenue by Region (2019-2024)
6.2 APAC Interventional Oncology Device Sales by Type
6.3 APAC Interventional Oncology Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Interventional Oncology Device by Country
7.1.1 Europe Interventional Oncology Device Sales by Country (2019-2024)
7.1.2 Europe Interventional Oncology Device Revenue by Country (2019-2024)
7.2 Europe Interventional Oncology Device Sales by Type
7.3 Europe Interventional Oncology Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Interventional Oncology Device by Country
8.1.1 Middle East & Africa Interventional Oncology Device Sales by Country (2019-2024)
8.1.2 Middle East & Africa Interventional Oncology Device Revenue by Country (2019-2024)
8.2 Middle East & Africa Interventional Oncology Device Sales by Type
8.3 Middle East & Africa Interventional Oncology Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Interventional Oncology Device
10.3 Manufacturing Process Analysis of Interventional Oncology Device
10.4 Industry Chain Structure of Interventional Oncology Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Interventional Oncology Device Distributors
11.3 Interventional Oncology Device Customer
12 World Forecast Review for Interventional Oncology Device by Geographic Region
12.1 Global Interventional Oncology Device Market Size Forecast by Region
12.1.1 Global Interventional Oncology Device Forecast by Region (2025-2030)
12.1.2 Global Interventional Oncology Device Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Interventional Oncology Device Forecast by Type
12.7 Global Interventional Oncology Device Forecast by Application
13 Key Players Analysis
13.1 AngioDynamics, Inc.
13.1.1 AngioDynamics, Inc. Company Information
13.1.2 AngioDynamics, Inc. Interventional Oncology Device Product Portfolios and Specifications
13.1.3 AngioDynamics, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 AngioDynamics, Inc. Main Business Overview
13.1.5 AngioDynamics, Inc. Latest Developments
13.2 BD
13.2.1 BD Company Information
13.2.2 BD Interventional Oncology Device Product Portfolios and Specifications
13.2.3 BD Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 BD Main Business Overview
13.2.5 BD Latest Developments
13.3 Boston Scientific Corporation
13.3.1 Boston Scientific Corporation Company Information
13.3.2 Boston Scientific Corporation Interventional Oncology Device Product Portfolios and Specifications
13.3.3 Boston Scientific Corporation Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Boston Scientific Corporation Main Business Overview
13.3.5 Boston Scientific Corporation Latest Developments
13.4 BTG Plc
13.4.1 BTG Plc Company Information
13.4.2 BTG Plc Interventional Oncology Device Product Portfolios and Specifications
13.4.3 BTG Plc Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 BTG Plc Main Business Overview
13.4.5 BTG Plc Latest Developments
13.5 Eckert & Ziegler BEBIG
13.5.1 Eckert & Ziegler BEBIG Company Information
13.5.2 Eckert & Ziegler BEBIG Interventional Oncology Device Product Portfolios and Specifications
13.5.3 Eckert & Ziegler BEBIG Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Eckert & Ziegler BEBIG Main Business Overview
13.5.5 Eckert & Ziegler BEBIG Latest Developments
13.6 HealthTronics, Inc.
13.6.1 HealthTronics, Inc. Company Information
13.6.2 HealthTronics, Inc. Interventional Oncology Device Product Portfolios and Specifications
13.6.3 HealthTronics, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 HealthTronics, Inc. Main Business Overview
13.6.5 HealthTronics, Inc. Latest Developments
13.7 IceCure Medical
13.7.1 IceCure Medical Company Information
13.7.2 IceCure Medical Interventional Oncology Device Product Portfolios and Specifications
13.7.3 IceCure Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 IceCure Medical Main Business Overview
13.7.5 IceCure Medical Latest Developments
13.8 Medtronic PLC
13.8.1 Medtronic PLC Company Information
13.8.2 Medtronic PLC Interventional Oncology Device Product Portfolios and Specifications
13.8.3 Medtronic PLC Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Medtronic PLC Main Business Overview
13.8.5 Medtronic PLC Latest Developments
13.9 Medwaves, Inc.
13.9.1 Medwaves, Inc. Company Information
13.9.2 Medwaves, Inc. Interventional Oncology Device Product Portfolios and Specifications
13.9.3 Medwaves, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Medwaves, Inc. Main Business Overview
13.9.5 Medwaves, Inc. Latest Developments
13.10 Merit Medical Systems, Inc.
13.10.1 Merit Medical Systems, Inc. Company Information
13.10.2 Merit Medical Systems, Inc. Interventional Oncology Device Product Portfolios and Specifications
13.10.3 Merit Medical Systems, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Merit Medical Systems, Inc. Main Business Overview
13.10.5 Merit Medical Systems, Inc. Latest Developments
13.11 Sanarus Technologies, Inc.
13.11.1 Sanarus Technologies, Inc. Company Information
13.11.2 Sanarus Technologies, Inc. Interventional Oncology Device Product Portfolios and Specifications
13.11.3 Sanarus Technologies, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Sanarus Technologies, Inc. Main Business Overview
13.11.5 Sanarus Technologies, Inc. Latest Developments
13.12 Sirtex Medical Ltd.
13.12.1 Sirtex Medical Ltd. Company Information
13.12.2 Sirtex Medical Ltd. Interventional Oncology Device Product Portfolios and Specifications
13.12.3 Sirtex Medical Ltd. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Sirtex Medical Ltd. Main Business Overview
13.12.5 Sirtex Medical Ltd. Latest Developments
13.13 Sonacare Medical
13.13.1 Sonacare Medical Company Information
13.13.2 Sonacare Medical Interventional Oncology Device Product Portfolios and Specifications
13.13.3 Sonacare Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Sonacare Medical Main Business Overview
13.13.5 Sonacare Medical Latest Developments
13.14 Terumo Corporation
13.14.1 Terumo Corporation Company Information
13.14.2 Terumo Corporation Interventional Oncology Device Product Portfolios and Specifications
13.14.3 Terumo Corporation Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Terumo Corporation Main Business Overview
13.14.5 Terumo Corporation Latest Developments
13.15 Trod Medical
13.15.1 Trod Medical Company Information
13.15.2 Trod Medical Interventional Oncology Device Product Portfolios and Specifications
13.15.3 Trod Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Trod Medical Main Business Overview
13.15.5 Trod Medical Latest Developments
13.16 Cook Meidical LLC
13.16.1 Cook Meidical LLC Company Information
13.16.2 Cook Meidical LLC Interventional Oncology Device Product Portfolios and Specifications
13.16.3 Cook Meidical LLC Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Cook Meidical LLC Main Business Overview
13.16.5 Cook Meidical LLC Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
